E H Baker1, S W Ross2, R Seshadri1, R Z Swan1, D A Iannitti1, D Vrochides1, J B Martinie1. 1. Department of General Surgery, Division of Hepato-pancreato-biliary Surgery, Carolinas Medical Center, Charlotte, NC, USA. 2. Department of General Surgery, Carolinas Medical Center, Charlotte, NC, USA.
Abstract
BACKGROUND: Robotic pancreaticoduodenectomy (RP) has shown some advantages over open pancreaticoduodenectomy (OP) but no data has been published providing a cost comparison. METHODS: Retrospective analysis of all pancreaticoduodenectomies at a single quaternary cancer referral center was performed. Patient demographics, comorbidities, operative characteristics, complications, and charge data were recorded, and then compared using standard statistical methods. RESULTS: 71 pancreaticoduodenectomies were performed: 22 RP and 49 OP. Patients undergoing OP had similar demographics, comorbidities, pathology, and oncologic characteristics as patients undergoing RP. While operative charges were higher for RP, once inpatient stay associated costs and follow-up costs were included, there was no difference in total costs between RP and OP. CONCLUSIONS: Patients undergoing RP have equivalent rates of R0 resection as OP, and benefit from decreased number of complications, surgical site infections, and length of stay in the intensive care unit. Once cost of complications and follow-up are incorporated, no significant difference between procedures exists.
BACKGROUND: Robotic pancreaticoduodenectomy (RP) has shown some advantages over open pancreaticoduodenectomy (OP) but no data has been published providing a cost comparison. METHODS: Retrospective analysis of all pancreaticoduodenectomies at a single quaternary cancer referral center was performed. Patient demographics, comorbidities, operative characteristics, complications, and charge data were recorded, and then compared using standard statistical methods. RESULTS: 71 pancreaticoduodenectomies were performed: 22 RP and 49 OP. Patients undergoing OP had similar demographics, comorbidities, pathology, and oncologic characteristics as patients undergoing RP. While operative charges were higher for RP, once inpatient stay associated costs and follow-up costs were included, there was no difference in total costs between RP and OP. CONCLUSIONS:Patients undergoing RP have equivalent rates of R0 resection as OP, and benefit from decreased number of complications, surgical site infections, and length of stay in the intensive care unit. Once cost of complications and follow-up are incorporated, no significant difference between procedures exists.
Authors: Claudio Ricci; Riccardo Casadei; Giovanni Taffurelli; Carlo Alberto Pacilio; Marco Ricciardiello; Francesco Minni Journal: World J Surg Date: 2018-03 Impact factor: 3.352
Authors: James C Patti; Ana Sofia Ore; Courtney Barrows; Vic Velanovich; A James Moser Journal: Hepatobiliary Surg Nutr Date: 2017-08 Impact factor: 7.293